NCT06304038View on ClinicalTrials.gov

Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

CompletedOBSERVATIONAL
Enrollment

5,483

Participants

Timeline

Start Date

October 16, 2017

Primary Completion Date

April 29, 2018

Study Completion Date

November 14, 2019

Conditions
Influenza VaccineCost-Benefit Analysis
Interventions
DRUG

Flu Vaccine

Administration of quadrivalent split inactivated non-adjuvanted flu vaccine Fluarix Tetra

Trial Locations (1)

00168

"Fondazione Policlinico Universitario A.Gemelli IRCCS", Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06304038 - Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome | Biotech Hunter | Biotech Hunter